tiprankstipranks
Advertisement
Advertisement

ONCY Stock Latest News

Oncolytics Biotech: Buy Rating on Pelareorep’s Advancing Registrational Path and Oncolytic Virus Sector Tailwinds
RatingsOncolytics Biotech: Buy Rating on Pelareorep’s Advancing Registrational Path and Oncolytic Virus Sector Tailwinds
4d ago
ONCY
Oncolytics price target lowered to $5 from $7 at Lake Street
PremiumThe Fly
Oncolytics price target lowered to $5 from $7 at Lake Street
5d ago
ONCY
Oncolytics Biotech Establishes $75 Million ATM Offering
PremiumCompany Announcements
Oncolytics Biotech Establishes $75 Million ATM Offering
6d ago
8K
ONCY
Oncolytics Plans FDA Meeting for Pelareorep SCAC Study
PremiumCompany Announcements
Oncolytics Plans FDA Meeting for Pelareorep SCAC Study
6d ago
8K
ONCY
Oncolytics schedules FDA meeting for pelareorep registrational path
PremiumThe Fly
Oncolytics schedules FDA meeting for pelareorep registrational path
6d ago
ONCY
Oncolytics Biotech Completes Domestication to Nevada with New Governance
PremiumCompany AnnouncementsOncolytics Biotech Completes Domestication to Nevada with New Governance
11d ago
8K
ONCY
Oncolytics completes domicile change to the U.S.
Premium
The Fly
Oncolytics completes domicile change to the U.S.
11d ago
ONCY
Oncolytics files $250M mixed securities shelf
Premium
The Fly
Oncolytics files $250M mixed securities shelf
12d ago
ONCY
Oncolytics Biotech Shifts Corporate Domicile to British Columbia
PremiumCompany Announcements
Oncolytics Biotech Shifts Corporate Domicile to British Columbia
23d ago
8K
ONCY
Oncolytics Biotech Showcases Pelareorep as Immune-Priming Backbone With New AACR 2026 Data
PremiumCompany Announcements
Oncolytics Biotech Showcases Pelareorep as Immune-Priming Backbone With New AACR 2026 Data
24d ago
ONCY
Oncolytics Highlights New Pelareorep Data in Cancer Immunotherapy
PremiumCompany Announcements
Oncolytics Highlights New Pelareorep Data in Cancer Immunotherapy
24d ago
8K
ONCY
Oncolytics to present new data on Pelareorep at AACR 2026
PremiumThe Fly
Oncolytics to present new data on Pelareorep at AACR 2026
24d ago
ONCY
Oncolytics Biotech Advances Pelareorep Into New Phase 2 Colorectal Cancer Study
PremiumCompany AnnouncementsOncolytics Biotech Advances Pelareorep Into New Phase 2 Colorectal Cancer Study
1M ago
ONCY
Is ONCY a Buy, Before Earnings?
Premium
Pre-Earnings
Is ONCY a Buy, Before Earnings?
1M ago
ONCY
Oncolytics Biotech Launches Phase 2 Colorectal Cancer Trial
Premium
Company Announcements
Oncolytics Biotech Launches Phase 2 Colorectal Cancer Trial
1M ago
8K
ONCY
Oncolytics initiates randomized colorectal cancer study
PremiumThe Fly
Oncolytics initiates randomized colorectal cancer study
1M ago
ONCY
Oncolytics Refocuses Pipeline on Key GI Cancer Programs
PremiumCompany Announcements
Oncolytics Refocuses Pipeline on Key GI Cancer Programs
2M ago
8K
ONCY
Oncolytics concludes enrollment in GOBLET study
PremiumThe Fly
Oncolytics concludes enrollment in GOBLET study
2M ago
ONCY
Oncolytics Biotech receives FDA Fast Track for pelareorep
PremiumCompany Announcements
Oncolytics Biotech receives FDA Fast Track for pelareorep
2M ago
8K
ONCY
Pelareorep Platform Breakthrough Drives $10 Target and Buy Rating on Oncolytics Biotech
PremiumRatingsPelareorep Platform Breakthrough Drives $10 Target and Buy Rating on Oncolytics Biotech
2M ago
ONCY
Oncolytics receives FDA Fast Track Designation for pelareorep
Premium
The Fly
Oncolytics receives FDA Fast Track Designation for pelareorep
2M ago
ONCY
Dave & Buster’s, American Eagle, Cabaletta, Abeona, Oncolytics Insider Shock
Premium
Weekend Updates
Dave & Buster’s, American Eagle, Cabaletta, Abeona, Oncolytics Insider Shock
3M ago
AEO
ABEO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >